KLOW

A defined four-peptide blend. KLOW is a fixed-ratio blend of four separately characterised research peptides, co-lyophilized into one vial. Where the rest of the catalog is single-molecule material, KLOW is deliberately a mixture: these four components are studied together across repair- and matrix-oriented research, and supplying them pre-blended to a defined specification removes the weighing and handling error that combining four separate vials introduces into every experiment. Brightly supplies it as a lyophilized (freeze-dried) powder in a sealed, tamper-evident vial, prepared and handled strictly as a characterised reference material for in-vitro laboratory research.

Each component is a defined peptide in its own right, and the blend is weighed to the same split on every lot:

Because the ratio is fixed and every component is verified on the lot-specific Certificate of Analysis, KLOW gives researchers a consistent multi-component reference point. That matters in blend research, where an unknown or drifting ratio between components would confound any comparison between experiments.

Supplied strictly as a characterised reference material for in-vitro and preclinical laboratory work, not for any diagnostic or therapeutic purpose.

Research overview

KLOW is supplied as a characterised reference material for controlled in-vitro and preclinical laboratory work. Each component is synthesised and purified to industry-standard protocols before blending, making the material suitable for analytical testing, tissue-repair models, and extracellular-matrix research. Every lot is verified by HPLC for purity and identity, component by component, with a lot-specific Certificate of Analysis included.

Research-grade standards behind each batch

• Each component synthesised via solid-phase peptide synthesis (SPPS)
• Purified using preparative HPLC before blending
• Blended to a fixed, documented ratio
• Screened for endotoxins by LAL
• Identity of each component confirmed by HPLC

Why researchers study KLOW

Published in-vitro and preclinical literature examines each of these four peptides across overlapping repair, matrix-remodeling and inflammatory-signaling processes, which makes the combination of interest as a multi-component tool for studying how those pathways interact under controlled conditions. Areas of scientific interest include:

• Tissue-repair models
• Extracellular-matrix (ECM) remodeling
• Dermal and connective-tissue research
• Angiogenesis and endothelial-signaling pathways
• Inflammatory-signaling and melanocortin-pathway studies
• Copper(II) transport and metal-ion delivery mechanisms

The four components

Each is a defined peptide with a research literature of its own, and the blend is studied as a combination of those four profiles rather than as a new single entity.

KPV. The C-terminal tripeptide fragment (Lys-Pro-Val) of alpha-melanocyte-stimulating hormone, studied in inflammatory-signaling and melanocortin-pathway models.

BPC-157. A synthetic 15-residue peptide studied in tissue-repair, gastrointestinal mucosal-integrity, and angiogenesis models.

TB-500. A thymosin β4 fragment studied in actin-binding, cell-migration, and connective-tissue repair models.

GHK-Cu. A copper(II) tripeptide complex studied in extracellular-matrix remodeling, dermal research, and copper-transport mechanisms. It carries the largest share of the blend by mass, consistent with how it is dosed in the copper-peptide literature relative to the other three.

Pre-blended vs four separate vials

Supplied strictly as a characterised reference material for in-vitro and preclinical laboratory work, not for any diagnostic or therapeutic purpose.

Every lot of KLOW follows a controlled, pharma-grade workflow from synthesis to fulfilment, so the material stays consistent, pure, and stable.

Cleanroom manufacturing

Synthesised in controlled, low-contamination environments for batch-to-batch consistency.

≥98%, per component HPLC-verified purity

Purity confirmed by high-performance liquid chromatography (HPLC).

Verified identity & purity

Identity and purity confirmed by HPLC, and endotoxin by Limulus Amebocyte Lysate (LAL).

Endotoxin-controlled

Low endotoxin levels matter in sensitive cell-based and signaling studies, where inflammatory contaminants could confound results.

Pharma-grade raw materials

Synthesis begins with tested amino acids and validated reagents to protect molecular integrity.

Lyophilized for stability

Freeze-drying preserves structural integrity during shipping, storage, and handling.

Nitrogen-sealed vials

Vials are sealed under nitrogen to limit exposure to oxygen and moisture.

Understanding lyophilization. Freeze-drying removes moisture by freezing the material and lowering pressure so water sublimates directly from solid to vapour, leaving a stable, dry powder that tolerates storage well for long-term studies.

Before reconstitution. Unopened lyophilized KLOW tolerates short periods at room temperature in a cool, dry place away from heat, humidity, and light. For longer storage, keep sealed vials frozen: −20 °C is common, while −80 °C adds margin for long-term or archival storage.

After reconstitution. Reconstitute with bacteriostatic water, then keep the solution refrigerated below 4 °C, aliquot to working volumes, and avoid repeated freeze-thaw cycles. Under appropriate laboratory conditions, reconstituted solutions typically remain stable for up to 30 days, following your own laboratory protocol.

Same-day dispatch (USA)

In-stock orders placed before 1:00 PM CT ship the same business day.

Fast domestic delivery

Free FedEx shipping on every order; express delivery is free on orders over $150.

Protective handling

Vials are held in temperature-controlled storage before shipment; the lyophilized powder is stable for ambient transit and is packed to limit temperature swings, moisture, and physical damage.

Tracking and guarantee

Tracking is provided at shipment, and every order is backed by our 30-day money-back guarantee.

See our Shipping and Refund policies for full details.